{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:29:59Z","timestamp":1774124999111,"version":"3.50.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1038\/nrd2310","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T05:43:36Z","timestamp":1180676616000},"page":"443-453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1018,"title":["Interfering with disease: a progress report on siRNA-based therapeutics"],"prefix":"10.1038","volume":"6","author":[{"given":"Antonin","family":"de Fougerolles","sequence":"first","affiliation":[]},{"given":"Hans-Peter","family":"Vornlocher","sequence":"additional","affiliation":[]},{"given":"John","family":"Maraganore","sequence":"additional","affiliation":[]},{"given":"Judy","family":"Lieberman","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnrd2310_CR1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/35888","volume":"391","author":"A Fire","year":"1998","unstructured":"Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806\u2013811 (1998).","journal-title":"Nature"},{"key":"BFnrd2310_CR2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","volume":"411","author":"SM Elbashir","year":"2001","unstructured":"Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494\u2013498 (2001).","journal-title":"Nature"},{"key":"BFnrd2310_CR3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nm828","volume":"9","author":"E Song","year":"2003","unstructured":"Song, E. et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nature Med. 9, 347\u2013351 (2003).","journal-title":"Nature Med."},{"key":"BFnrd2310_CR4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature02873","volume":"431","author":"G Meister","year":"2004","unstructured":"Meister, G. & Tuschl, T. Mechanisms of gene silencing by double-stranded RNA. Nature 431, 343\u2013349 (2004).","journal-title":"Nature"},{"key":"BFnrd2310_CR5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrg2006","volume":"8","author":"DH Kim","year":"2007","unstructured":"Kim, D. H. & Rossi, J. J. Strategies for silencing human disease using RNA interference. Nature Rev. Genet. 8, 173\u2013184 (2007).","journal-title":"Nature Rev. Genet."},{"key":"BFnrd2310_CR6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","volume":"5","author":"L He","year":"2004","unstructured":"He, L. & Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nature Rev. Genet. 5, 522\u2013531 (2004).","journal-title":"Nature Rev. Genet."},{"key":"BFnrd2310_CR7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2005.08.044","volume":"123","author":"C Matranga","year":"2005","unstructured":"Matranga, C. et al. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 123, 607\u2013620 (2005).","journal-title":"Cell"},{"key":"BFnrd2310_CR8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/ncb1274","volume":"7","author":"J Liu","year":"2005","unstructured":"Liu, J. et al. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nature Cell Biol. 7, 719\u2013723 (2005).","journal-title":"Nature Cell Biol."},{"key":"BFnrd2310_CR9","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1126\/science.1073827","volume":"297","author":"G Hutvagner","year":"2002","unstructured":"Hutvagner, G. & Zamore, P. D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 297, 2056\u20132060 (2002).","journal-title":"Science"},{"key":"BFnrd2310_CR10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","volume":"441","author":"D Grimm","year":"2006","unstructured":"Grimm, D. et al. Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways. Nature 441, 537\u2013541 (2006).","journal-title":"Nature"},{"key":"BFnrd2310_CR11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nmeth911","volume":"3","author":"Y Pei","year":"2006","unstructured":"Pei, Y. & Tuschl, T. On the art of identifying effective and specific siRNAs. Nature Methods 3, 670\u2013676 (2006).","journal-title":"Nature Methods"},{"key":"BFnrd2310_CR12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nbt936","volume":"22","author":"A Reynolds","year":"2004","unstructured":"Reynolds, A. et al. Rational siRNA design for RNA interference. Nature Biotechnol. 22, 326\u2013330 (2004).","journal-title":"Nature Biotechnol."},{"key":"BFnrd2310_CR13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt1051","volume":"23","author":"DH Kim","year":"2005","unstructured":"Kim, D. H. et al. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nature Biotechnol. 23, 222\u2013226 (2005).","journal-title":"Nature Biotechnol."},{"key":"BFnrd2310_CR14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1261\/rna.2340906","volume":"6","author":"A Reynolds","year":"2006","unstructured":"Reynolds, A. et al. Induction of the interferon response by siRNA is cell type- and duplex length-dependent. RNA 6, 988\u2013993 (2006).","journal-title":"RNA"},{"key":"BFnrd2310_CR15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0092-8674(03)00759-1","volume":"115","author":"DS Schwarz","year":"2003","unstructured":"Schwarz, D. S. et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199\u2013208 (2003).","journal-title":"Cell"},{"key":"BFnrd2310_CR16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(03)00801-8","volume":"115","author":"A Khvorova","year":"2003","unstructured":"Khvorova, A., Reynolds, A. & Jayasena, S. D. Functional siRNAs and miRNAs exhibit strand bias. Cell 115, 209\u2013216 (2003).","journal-title":"Cell"},{"key":"BFnrd2310_CR17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1097-2765(03)00348-4","volume":"12","author":"P Aza-Blanc","year":"2003","unstructured":"Aza-Blanc, P. et al. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol. Cell 12, 627\u2013637 (2003).","journal-title":"Mol. Cell"},{"key":"BFnrd2310_CR18","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1371\/journal.pgen.0020140","volume":"2","author":"DS Schwarz","year":"2006","unstructured":"Schwarz, D. S. et al. Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genetics 2, 1307\u20131318 (2006).","journal-title":"PLoS Genetics"},{"key":"BFnrd2310_CR19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nbt831","volume":"21","author":"AL Jackson","year":"2003","unstructured":"Jackson, A. L. et al. Expression profiling reveals off-target gene regulation by RNAi. Nature Biotech. 21, 635\u2013637 (2003).","journal-title":"Nature Biotech."},{"key":"BFnrd2310_CR20","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1093\/nar\/gki762","volume":"33","author":"X Lin","year":"2005","unstructured":"Lin, X. et al. siRNA-mediated off-target gene silencing triggered by a 7 nt complementation. Nucleic Acids Res. 33, 4527\u20134535 (2005).","journal-title":"Nucleic Acids Res."},{"key":"BFnrd2310_CR21","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/nar\/gki324","volume":"33","author":"S Qiu","year":"2005","unstructured":"Qiu, S., Adema, C. M. & Lane, T. A computational study of off-target effects of RNA interference. Nucleic Acids Res. 33, 1834\u20131847 (2005).","journal-title":"Nucleic Acids Res."},{"key":"BFnrd2310_CR22","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1261\/rna.25706","volume":"12","author":"AL Jackson","year":"2006","unstructured":"Jackson, A. L. et al. Widespread siRNA off-target transcript silencing mediated by seed region sequence complementarity. RNA 12, 1179\u20131187 (2006).","journal-title":"RNA"},{"key":"BFnrd2310_CR23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nmeth854","volume":"3","author":"A Birmingham","year":"2006","unstructured":"Birmingham, A. et al. 3\u2032 UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nature Methods 3, 199\u2013204 (2006).","journal-title":"Nature Methods"},{"key":"BFnrd2310_CR24","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1261\/rna.30706","volume":"12","author":"AL Jackson","year":"2006","unstructured":"Jackson, A. L. et al. Position-specific chemical modification of siRNAs reduces off-target transcript silencing. RNA 12, 1197\u20131205 (2006).","journal-title":"RNA"},{"key":"BFnrd2310_CR25","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1261\/rna.28106","volume":"12","author":"Y Fedorov","year":"2006","unstructured":"Fedorov, Y. et al. Off-target effects by siRNA can induce toxic phenotype. RNA 12, 1188\u20131196 (2006).","journal-title":"RNA"},{"key":"BFnrd2310_CR26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ymthe.2006.06.001","volume":"14","author":"M Schlee","year":"2006","unstructured":"Schlee, M. et al. SiRNA and isRNA: two edges of one sword. Mol. Ther. 14, 463\u2013470 (2006).","journal-title":"Mol. Ther."},{"key":"BFnrd2310_CR27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm1191","volume":"11","author":"V Hornung","year":"2005","unstructured":"Hornung, V. et al. Sequence-specific potent induction of IFN-\u03b1 by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nature Med. 11, 263\u2013270 (2005).","journal-title":"Nature Med."},{"key":"BFnrd2310_CR28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nbt1081","volume":"23","author":"AD Judge","year":"2005","unstructured":"Judge, A. D. et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nature Biotechnol. 23, 457\u2013462 (2005).","journal-title":"Nature Biotechnol."},{"key":"BFnrd2310_CR29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ymthe.2005.11.002","volume":"13","author":"AD Judge","year":"2006","unstructured":"Judge, A. D. et al. Design of non-inflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol. Ther. 13, 494\u2013505 (2006).","journal-title":"Mol. Ther."},{"key":"BFnrd2310_CR30","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1261\/rna.5239604","volume":"10","author":"JM Layzer","year":"2004","unstructured":"Layzer, J. M. et al. In vivo activity of nuclease-resistant siRNAs. RNA 10, 766\u2013771 (2004).","journal-title":"RNA"},{"key":"BFnrd2310_CR31","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbrc.2006.02.049","volume":"342","author":"S Choung","year":"2006","unstructured":"Choung, S. et al. Chemical modification of siRNAs to improve serum stability without loss of efficacy. Biochem. Biophys. Res. Commun 342, 919\u2013927 (2006).","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"BFnrd2310_CR32","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/jm049167j","volume":"48","author":"CR Allerson","year":"2005","unstructured":"Allerson, C. R. et al. Fully 2\u2032-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J. Med. Chem. 48, 901\u2013904 (2005).","journal-title":"J. Med. Chem."},{"key":"BFnrd2310_CR33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0076-6879(04)92016-2","volume":"392","author":"AR de Fougerolles","year":"2005","unstructured":"de Fougerolles, A. R. et al. RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeutics. Methods Enzymol. 392, 278\u2013296 (2005).","journal-title":"Methods Enzymol."},{"key":"BFnrd2310_CR34","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.20702","volume":"41","author":"DV Morrissey","year":"2005","unstructured":"Morrissey, D. V. et al. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology 41, 1349\u20131356 (2005).","journal-title":"Hepatology"},{"key":"BFnrd2310_CR35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/nar\/gkj439","volume":"34","author":"DW Bartlett","year":"2006","unstructured":"Bartlett, D. W. & Davis, M. E. Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Res. 34, 322\u2013333 (2006).","journal-title":"Nucleic Acids Res."},{"key":"BFnrd2310_CR36","doi-asserted-by":"crossref","first-page":"10614","DOI":"10.1021\/bi060351b","volume":"45","author":"K Raemdonck","year":"2006","unstructured":"Raemdonck, K. et al. In situ analysis of single-stranded and duplex siRNA integrity in living cells. Biochemistry 45, 10614\u201310623 (2006).","journal-title":"Biochemistry"},{"key":"BFnrd2310_CR37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nmeth0405-241","volume":"2","author":"Y Fedorov","year":"2005","unstructured":"Fedorov, Y. et al. Different delivery methods-different expression profiles. Nature Methods 2, 241 (2005).","journal-title":"Nature Methods"},{"key":"BFnrd2310_CR38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jbiotec.2005.12.003","volume":"124","author":"A Aigner","year":"2006","unstructured":"Aigner, A. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. J. Biotechnology 124, 12\u201325 (2006).","journal-title":"J. Biotechnology"},{"key":"BFnrd2310_CR39","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nchembio839","volume":"2","author":"D Bumcrot","year":"2006","unstructured":"Bumcrot, D. et al. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nature Chem. Biol. 2, 711\u2013719 (2006).","journal-title":"Nature Chem. Biol."},{"key":"BFnrd2310_CR40","first-page":"210","volume":"9","author":"SJ Reich","year":"2003","unstructured":"Reich, S. J. et al. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol. Vision 9, 210\u2013216 (2003).","journal-title":"Mol. Vision"},{"key":"BFnrd2310_CR41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00006982-200402000-00018","volume":"24","author":"MJ Tolentino","year":"2004","unstructured":"Tolentino, M. J. et al. Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization. Retina 24, 132\u2013138 & 660\u2013661 (2004).","journal-title":"Retina"},{"key":"BFnrd2310_CR42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.gt.3302641","volume":"13","author":"J Shen","year":"2006","unstructured":"Shen, J. et al. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther. 13, 225\u2013234 (2006).","journal-title":"Gene Ther."},{"key":"BFnrd2310_CR43","first-page":"703","volume":"10","author":"H Nakamura","year":"2004","unstructured":"Nakamura, H. et al. RNA interference targeting transforming growth factor-\u03b2 type II receptor suppresses ocular inflammation and fibrosis. Mol. Vision 10, 703\u2013711 (2004).","journal-title":"Mol. Vision"},{"key":"BFnrd2310_CR44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm1164","volume":"11","author":"V Bitko","year":"2005","unstructured":"Bitko, V. et al. Inhibition of respiratory viruses by nasally administered siRNA. Nature Med. 11, 50\u201355 (2005).","journal-title":"Nature Med."},{"key":"BFnrd2310_CR45","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm1280","volume":"11","author":"BJ Li","year":"2005","unstructured":"Li, B. J. et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nature Med. 11, 944\u2013951 (2005).","journal-title":"Nature Med."},{"key":"BFnrd2310_CR46","doi-asserted-by":"crossref","first-page":"10677","DOI":"10.1074\/jbc.M312941200","volume":"279","author":"X Zhang","year":"2004","unstructured":"Zhang, X. et al. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J. Biol. Chem. 279, 10677\u201310684 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2310_CR47","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1189\/jlb.1004617","volume":"77","author":"JL Lomas-Neira","year":"2005","unstructured":"Lomas-Neira, J. L. et al.. In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury. J. Leukoc. Biol. 77, 846\u2013853 (2005).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrd2310_CR48","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0002-9440(10)61240-0","volume":"167","author":"M Perl","year":"2005","unstructured":"Perl, M. et al. Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation and neutrophil influx after hemorrhagic shock and sepsis. Am. J. Pathol. 167, 1545\u20131559 (2005).","journal-title":"Am. J. Pathol."},{"key":"BFnrd2310_CR49","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/nm1494","volume":"12","author":"V Bhandari","year":"2006","unstructured":"Bhandari, V. et al. Hypoxia causes angiopoietin-2-mediated acute lung injury and necrotic cell death. Nature Med. 12, 1286\u20131292 (2006).","journal-title":"Nature Med."},{"key":"BFnrd2310_CR50","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.4049\/jimmunol.176.3.1928","volume":"176","author":"W Matsuyama","year":"2006","unstructured":"Matsuyama, W. et al. Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation. J. Immunol. 176, 1928\u20131936 (2006).","journal-title":"J. Immunol."},{"key":"BFnrd2310_CR51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2202-3-18","volume":"3","author":"H Makimura","year":"2002","unstructured":"Makimura, H. et al. Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake. BMC Neurosci. 3, 18 (2002).","journal-title":"BMC Neurosci."},{"key":"BFnrd2310_CR52","doi-asserted-by":"crossref","first-page":"17270","DOI":"10.1073\/pnas.0406214101","volume":"101","author":"DR Thakker","year":"2004","unstructured":"Thakker, D. R. et al. Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. Proc. Natl Acad. Sci. USA 101, 17270\u201317275 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2310_CR53","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/sj.mp.4001687","volume":"10","author":"DR Thakker","year":"2005","unstructured":"Thakker, D. R. et al. siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain. Mol. Psychiatry 10, 782\u2013789 (2005).","journal-title":"Mol. Psychiatry"},{"key":"BFnrd2310_CR54","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1093\/nar\/gnh044","volume":"32","author":"G Dorn","year":"2004","unstructured":"Dorn, G. et al. SiRNA relieves chronic neuropathic pain. Nucleic Acids Res. 32, e49 (2004).","journal-title":"Nucleic Acids Res."},{"key":"BFnrd2310_CR55","first-page":"29","volume":"1","author":"MC Luo","year":"2005","unstructured":"Luo, M. C. et al. An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons. Mol. Pain 1, 29 (2005).","journal-title":"Mol. Pain"},{"key":"BFnrd2310_CR56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.gt.3302376","volume":"12","author":"PH Tan","year":"2005","unstructured":"Tan, P. H. et al. Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther. 12, 59\u201366 (2005).","journal-title":"Gene Ther."},{"key":"BFnrd2310_CR57","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1371\/journal.pmed.0030505","volume":"3","author":"P Kumar","year":"2006","unstructured":"Kumar, P. et al. A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med. 3, 505\u2013514 (2006).","journal-title":"PLoS Med."},{"key":"BFnrd2310_CR58","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1042\/bj3400783","volume":"340","author":"EA Biessen","year":"1999","unstructured":"Biessen, E. A. et al. Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo. Biochem. J. 340, 783\u2013792 (1999).","journal-title":"Biochem. J."},{"key":"BFnrd2310_CR59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature03121","volume":"432","author":"J Soutschek","year":"2004","unstructured":"Soutschek, J. et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432, 173\u2013178 (2004).","journal-title":"Nature"},{"key":"BFnrd2310_CR60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-5793(03)01505-9","volume":"558","author":"A Muratovska","year":"2004","unstructured":"Muratovska, A. & Eccles, M. R. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Letters 558, 63\u201368 (2004).","journal-title":"FEBS Letters"},{"key":"BFnrd2310_CR61","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.1158\/0008-5472.CAN-05-0565","volume":"65","author":"S Hu-Lieskovan","year":"2005","unstructured":"Hu-Lieskovan, S. et al. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res. 65, 8984\u20138992 (2005).","journal-title":"Cancer Res."},{"key":"BFnrd2310_CR62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jconrel.2005.02.006","volume":"104","author":"SH Kim","year":"2005","unstructured":"Kim, S. H. et al. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). J. Controlled Release 104, 223\u2013232 (2005).","journal-title":"J. Controlled Release"},{"key":"BFnrd2310_CR63","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1093\/nar\/gnh140","volume":"32","author":"RM Schiffelers","year":"2004","unstructured":"Schiffelers, R. M. et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 32, e149 (2004).","journal-title":"Nucleic Acids Res."},{"key":"BFnrd2310_CR64","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt1223","volume":"24","author":"JO McNamara","year":"2006","unstructured":"McNamara, J. O. et al. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nature Biotechnol. 24, 1005\u20131015 (2006).","journal-title":"Nature Biotechnol."},{"key":"BFnrd2310_CR65","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1093\/nar\/gkl388","volume":"34","author":"TC Chu","year":"2006","unstructured":"Chu, T. C. et al. Aptamer mediated siRNA delivery. Nucleic Acids Res. 34, e73 (2006).","journal-title":"Nucleic Acids Res."},{"key":"BFnrd2310_CR66","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev.med.56.062904.144915","volume":"56","author":"SM Nimjee","year":"2005","unstructured":"Nimjee, S. M., Rusconi, C. P. & Sullenger B.A. Aptamers: an emerging class of therapeutics. Annu. Rev. Med. 56, 555\u2013583 (2005).","journal-title":"Annu. Rev. Med."},{"key":"BFnrd2310_CR67","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev.bioeng.8.061505.095735","volume":"8","author":"VP Torchilin","year":"2006","unstructured":"Torchilin, V. P. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu. Rev. Biomed. Eng. 8, 343\u2013375 (2006).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"BFnrd2310_CR68","first-page":"438","volume":"24","author":"W Li","year":"2007","unstructured":"Li, W. Szoka F. C. Lipid-based nanoparticles for nucleic acid delivery. Pharm. Res. Adv. Drug Deliv. Rev. 24, 438\u2013449 (2007).","journal-title":"Pharm. Res. Adv. Drug Deliv. Rev."},{"key":"BFnrd2310_CR69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature04688","volume":"441","author":"TS Zimmermann","year":"2006","unstructured":"Zimmermann, T. S. et al. RNAi-mediated gene silencing in non-human primates. Nature 441, 111\u2013114 (2006).","journal-title":"Nature"},{"key":"BFnrd2310_CR70","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nbt1122","volume":"23","author":"DV Morrissey","year":"2005","unstructured":"Morrissey, D. V. et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nature Biotechnol. 23, 1002\u20131007 (2005).","journal-title":"Nature Biotechnol."},{"key":"BFnrd2310_CR71","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/504267","volume":"193","author":"TW Geisbert","year":"2006","unstructured":"Geisbert, T. W. et al. Postexposure protection of guinea pigs against lethal ebola virus challenge is conferred by RNA interference. J. Infect. Dis. 193, 1650\u20131657 (2006).","journal-title":"J. Infect. Dis."},{"key":"BFnrd2310_CR72","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/art.21876","volume":"54","author":"M Khoury","year":"2006","unstructured":"Khoury, M. et al. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor-\u03b1 in experimental arthritis. Arthritis & Rheumatism 54, 1867\u20131877 (2006).","journal-title":"Arthritis & Rheumatism"},{"key":"BFnrd2310_CR73","doi-asserted-by":"crossref","first-page":"L405","DOI":"10.1152\/ajplung.00292.2005","volume":"290","author":"K Miyawaki-Shimizu","year":"2006","unstructured":"Miyawaki-Shimizu, K. et al. SiRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L405\u2013L413 (2006).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"BFnrd2310_CR74","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/ijgc-00009577-200603000-00044","volume":"16","author":"XY Niu","year":"2006","unstructured":"Niu, X. Y. et al. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo. Int. J. Gynecol. Cancer 16, 743\u2013751 (2006).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"BFnrd2310_CR75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature04263","volume":"439","author":"D Palliser","year":"2006","unstructured":"Palliser, D. et al. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439, 89\u201394 (2006).","journal-title":"Nature"},{"key":"BFnrd2310_CR76","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ymthe.2006.04.001","volume":"4","author":"Y Zhang","year":"2006","unstructured":"Zhang, Y. et al. Engineering mucosal RNA interference in vivo. Mol. Ther. 4, 336\u2013342 (2006).","journal-title":"Mol. Ther."},{"key":"BFnrd2310_CR77","first-page":"132","volume":"7","author":"RL Juliano","year":"2005","unstructured":"Juliano, R. L. Peptide-oligonucleotide conjugates for the delivery of antisense and siRNA. Curr. Opin. Mol. Ther. 7, 132\u2013136 (2005).","journal-title":"Curr. Opin. Mol. Ther."},{"key":"BFnrd2310_CR78","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0169-409X(02)00046-7","volume":"54","author":"T Merdan","year":"2002","unstructured":"Merdan, T. et al. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug. Deliv. Rev. 54, 715\u2013758 (2002).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"BFnrd2310_CR79","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.addr.2003.10.041","volume":"56","author":"W Li","year":"2004","unstructured":"Li, W, Nicol, F. & Szoka F. C. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv. Drug Deliv. Rev. 56, 967\u2013985 (2004).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnrd2310_CR80","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijpharm.2006.11.050","volume":"331","author":"S Oliveira","year":"2007","unstructured":"Oliveira, S. et al. Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes. Int. J. Pharm. 2007 331, 211\u2013214 (2007).","journal-title":"Int. J. Pharm."},{"key":"BFnrd2310_CR81","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","volume":"92","author":"O Boussif","year":"1995","unstructured":"Boussif, O. et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl Acad. Sci. USA 92, 7297\u20137301 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2310_CR82","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.1073\/pnas.0402486101","volume":"101","author":"Q Ge","year":"2004","unstructured":"Ge, Q. et al. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl Acad. Sci. USA 101, 8676\u20138681 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2310_CR83","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/hum.2006.17.751","volume":"17","author":"M Grzelinski","year":"2006","unstructured":"Grzelinski, M. et al. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum. Gene Ther. 17, 751\u2013766 (2006).","journal-title":"Hum. Gene Ther."},{"key":"BFnrd2310_CR84","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.gt.3302425","volume":"12","author":"B Urban-Klein","year":"2005","unstructured":"Urban-Klein, B. et al. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 12, 461\u2013466 (2005).","journal-title":"Gene Ther."},{"key":"BFnrd2310_CR85","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1073\/pnas.0502067102","volume":"102","author":"M Thomas","year":"2005","unstructured":"Thomas, M. et al. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc. Natl Acad. Sci. USA 102, 5679\u20135684 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2310_CR86","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1007\/s11095-006-9009-2","volume":"23","author":"AC Grayson","year":"2006","unstructured":"Grayson, A. C. et al. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm. Res. 23, 1868\u20131876 (2006).","journal-title":"Pharm. Res."},{"key":"BFnrd2310_CR87","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2006.02.009","volume":"112","author":"S Werth","year":"2006","unstructured":"Werth, S. et al. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. J. Controlled Release 112, 257\u2013270 (2006).","journal-title":"J. Controlled Release"},{"key":"BFnrd2310_CR88","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1093\/nar\/gni085","volume":"33","author":"ML Read","year":"2005","unstructured":"Read, M. L. et al. A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res. 33, e86 (2005).","journal-title":"Nucleic Acids Res."},{"key":"BFnrd2310_CR89","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ymthe.2006.04.010","volume":"14","author":"KA Howard","year":"2006","unstructured":"Howard, K. A. et al. RNA interference in vitro and in vivo using a novel chitosan\/siRNA nanoparticle system. Mol. Ther. 14, 476\u2013484 (2006).","journal-title":"Mol. Ther."},{"key":"BFnrd2310_CR90","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1089\/hum.2006.17.1019","volume":"17","author":"JY Pille","year":"2006","unstructured":"Pille, J. Y. et al. Intravenous delivery of anti-rhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. Human Gene Ther. 17, 1019\u20131026 (2006).","journal-title":"Human Gene Ther."},{"key":"BFnrd2310_CR91","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1073\/pnas.0701458104","volume":"104","author":"JD Heidel","year":"2007","unstructured":"Heidel, J. D. et al. Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc. Natl Acad. Sci. USA 104, 5715\u20135721 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2310_CR92","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1158\/0008-5472.CAN-03-2682","volume":"64","author":"Y Takei","year":"2004","unstructured":"Takei, Y. et al. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res. 64, 3365\u20133370 (2004).","journal-title":"Cancer Res."},{"key":"BFnrd2310_CR93","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1349-7006.2006.00234.x","volume":"97","author":"F Takeshita","year":"2006","unstructured":"Takeshita, F. & Ochiya, T. Therapeutic potential of RNA interference against cancer. Cancer Sci. 97, 689\u2013696 (2006).","journal-title":"Cancer Sci."},{"key":"BFnrd2310_CR94","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/10611860400003858","volume":"12","author":"A Khan","year":"2004","unstructured":"Khan, A. et al. Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies. J. Drug Target 12, 393\u2013404 (2004).","journal-title":"J. Drug Target"},{"key":"BFnrd2310_CR95","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s11095-005-8330-5","volume":"22","author":"H Kang","year":"2005","unstructured":"Kang, H. et al. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides. Pharm. Res. 22, 2099\u20132106 (2005).","journal-title":"Pharm. Res."},{"key":"BFnrd2310_CR96","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.2174\/138161205774580769","volume":"11","author":"TS Zatsepin","year":"2005","unstructured":"Zatsepin, T. S. et al. Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agents. Curr. Pharm. Des. 11, 3639\u20133654 (2005).","journal-title":"Curr. Pharm. Des."},{"key":"BFnrd2310_CR97","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/nar\/gkg385","volume":"31","author":"F Simeoni","year":"2003","unstructured":"Simeoni, F. et al. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. 31, 2717\u20132724 (2003).","journal-title":"Nucleic Acids Res."},{"key":"BFnrd2310_CR98","doi-asserted-by":"crossref","first-page":"10040","DOI":"10.1523\/JNEUROSCI.3643-04.2004","volume":"24","author":"TJ Davidson","year":"2004","unstructured":"Davidson, T. J. et al. Highly efficient small interfering RNA delivery to primary mammalian neurons induces micro-RNA-like effects before mRNA degragation. J. Neurosci. 24, 10040\u201310046 (2004).","journal-title":"J. Neurosci."},{"key":"BFnrd2310_CR99","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ymthe.2006.03.022","volume":"14","author":"WJ Kim","year":"2006","unstructured":"Kim, W. J. et al. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol. Ther. 14, 343\u2013350 (2006).","journal-title":"Mol. Ther."},{"key":"BFnrd2310_CR100","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11095-006-9609-x","volume":"23","author":"KJ Longmuir","year":"2006","unstructured":"Longmuir, K. J. et al. Effective targeting of liposomes to liver and hepatocytes in vivo by incorporation of a Plasmodium amino acid sequence. Pharm. Res. 23, 759\u2013769 (2006).","journal-title":"Pharm. Res."},{"key":"BFnrd2310_CR101","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nbt1101","volume":"23","author":"E Song","year":"2005","unstructured":"Song, E. et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nature Biotechnol. 23, 709\u2013717 (2005).","journal-title":"Nature Biotechnol."},{"key":"BFnrd2310_CR102","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1073\/pnas.0608491104","volume":"104","author":"D Peer","year":"2007","unstructured":"Peer, D. et al. Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen 1. Proc. Natl Acad. Sci. USA 104, 4095\u20134100 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2310_CR103","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0002-9394(02)01325-9","volume":"133","author":"DA Jabs","year":"2002","unstructured":"Jabs, D. A. et al. Fomivirsen for the treatment of cytomegalovirus retinitis. Amer. J. Ophthalmol. 133, 552\u2013556 (2002).","journal-title":"Amer. J. Ophthalmol."},{"key":"BFnrd2310_CR104","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","volume":"351","author":"ES Gragoudas","year":"2004","unstructured":"Gragoudas, E. S. et al. Pegaptanib for neovascular age-related macular degeneration. N. Engl. J. Med. 351, 2805\u20132816 (2004).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrd2310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrd2310","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrd2310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:35:02Z","timestamp":1744371302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrd2310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":104,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["BFnrd2310"],"URL":"https:\/\/doi.org\/10.1038\/nrd2310","relation":{},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Antonin de Fougerolles, Hans-Peter Vornlocher and John Maraganore are employees of Alnylam Pharmaceuticals and have financial interests in Alnylam. Judy Lieberman is a member of the Scientific Advisory Board of Alnylam.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}